Copper and ceruloplasmin dyshomeostasis in serum and cerebrospinal fluid of multiple sclerosis subjects

被引:38
作者
De Riccardis, L. [1 ]
Buccolieri, A. [1 ]
Muci, M. [1 ]
Pitotti, E. [2 ]
De Robertis, F. [3 ]
Trianni, G. [3 ]
Manno, D. [4 ]
Maffia, M. [1 ,2 ]
机构
[1] Univ Salento, Dept Biol & Environm Sci & Technol, Via Monteroni, Lecce, Italy
[2] ASL Lecce, Giovanni Paolo Hosp 2, Lab Clin Prote, Lecce, Italy
[3] ASL Lecce, Vito Fazzi Hosp, Dept Neurol, Lecce, Italy
[4] Univ Salento, Dept Math & Phys Ennio De Giorgi, Lecce, Italy
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2018年 / 1864卷 / 05期
关键词
Multiple sclerosis; Copper; Ceruloplasmin; Serum; Cerebrospinal fluid; Oxidative stress; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASES; PARKINSONS-DISEASE; PROTEIN OXIDATION; SUPEROXIDE-DISMUTASE; FERROXIDASE ACTIVITY; WILSONS-DISEASE; BRAIN; ZINC; IRON;
D O I
10.1016/j.bbadis.2018.03.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although many studies have been carried out in order to understand the implication of copper (Cu) in the pathogenesis of multiple sclerosis (MS), the exact role that this metal plays in the disease is not still clear. Because of the lack of information in this subject, the present study compared the serum and cerebrospinal (CSF) levels of copper in MS patients in respect to a control group, matched for age and sex, finding a significant increase of metal concentrations, in both biological fluids of MS subjects. To confirm the possible impairment of Cu metabolism, we analyzed ceruloplasmin (Cp) level and activity, seeing as this protein is an established peripheral marker in diseases associated with Cu imbalance. By comparing these two parameters between control and MS subjects, we found an increase of Cp levels, associated with a decrease in Cp activity, in the second group. By analysing these data, free copper levels were calculated, significantly increased in serum of MS subjects; the increase in free copper could be one of the predisposing factors responsible for the Cu altered levels in CSF of MS patients. At the same time, this alteration could be attributable to the inability to incorporate Cu by Cp, probably due to the high oxidative environment found in serum of MS patients. Overall, all these copper alterations may play a role in MS pathogenesis.
引用
收藏
页码:1828 / 1838
页数:11
相关论文
共 50 条
  • [41] Adhesion molecule in the cerebrospinal fluid in multiple sclerosis
    Smagina, I. V.
    Fedyanin, A. S.
    El'Chaninova, S. A.
    Lobanov, M. N.
    Zolovkina, A. G.
    [J]. ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2011, 111 (11) : 53 - 55
  • [42] Cerebrospinal fluid markers in multiple sclerosis: an overview
    Massaro, AR
    Tonali, P
    [J]. MULTIPLE SCLEROSIS JOURNAL, 1998, 4 (01) : 1 - 4
  • [43] The prognostic significance of cerebrospinal fluid in multiple sclerosis
    Siritho, Sasitorn
    Freedman, Mark S.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 279 (1-2) : 21 - 25
  • [44] Multiple sclerosis with uncommon cerebrospinal fluid findings
    Rot, U
    Mesec, A
    Pogacnik, T
    [J]. CROATIAN MEDICAL JOURNAL, 2003, 44 (06) : 697 - 701
  • [45] Molecular Biomarkers in the Cerebrospinal Fluid in Multiple Sclerosis
    Shedko E.D.
    Tyumentseva M.A.
    [J]. Neuroscience and Behavioral Physiology, 2020, 50 (5) : 527 - 533
  • [46] Cine cerebrospinal fluid imaging in multiple sclerosis
    Magnano, Christopher
    Schirda, Claudiu
    Weinstock-Guttman, Bianca
    Wack, David S.
    Lindzen, Eric
    Hojnacki, David
    Bergsland, Niels
    Kennedy, Cheryl
    Belov, Pavel
    Dwyer, Michael G.
    Poloni, Guy U.
    Beggs, Clive B.
    Zivadinov, Robert
    [J]. JOURNAL OF MAGNETIC RESONANCE IMAGING, 2012, 36 (04) : 825 - 834
  • [47] Proteomic analysis of multiple sclerosis cerebrospinal fluid
    Hammack, BN
    Fung, KYC
    Hunsucker, SW
    Duncan, MW
    Burgoon, MP
    Owens, GP
    Gilden, DH
    [J]. MULTIPLE SCLEROSIS, 2004, 10 (03): : 245 - 260
  • [48] Examination of free kappa light chains in the cerebrospinal fluid and serum of multiple sclerosis patients
    Kalistova, H
    Havrdová, E
    Rasová, K
    Tyblová, M
    Zeman, D
    Benáková, H
    [J]. CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2005, 68 (02) : 90 - +
  • [49] Level of sFas/APO 1 in serum and cerebrospinal fluid in multiple sclerosis
    Mahovic, D
    Petravic, D
    Petelin, Z
    Zurak, N
    Horvat, G
    Hajnsek, S
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2004, 106 (03) : 230 - 232
  • [50] Specificities of multiple sclerosis cerebrospinal fluid and serum antibodies against mimotopes
    Jolivet-Reynaud, C
    Perron, H
    Ferrante, P
    Becquart, L
    Dalbon, P
    Mandrand, B
    [J]. CLINICAL IMMUNOLOGY, 1999, 93 (03) : 283 - 293